While MRE11 has been described as disrupted in over 60% of dMMR/MSI CRC, it has been suggested that MRE11 expression is strongly correlated with the activation of the immune response, as evidenced by higher levels of tumor-infiltrating inflammatory cells [31]. The gene discussed is MRE11; the disease is neoplasm.